TIMBER Psychotherapy and Ketamine Single Infusion in Chronic PTSD
NCT02766192 · The Cooper Health System
What it is testing
Summary
Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.
What counts as success
Primary outcome measures
Change from baseline scores on the Clinician Administered PTSD Scale (CAPS) at 25th hours post-infusion
Measured over For CAPS, change in scores at 25th hour post-infusion compared to the baseline were measured
Change from baseline scores on the PTSD Symptom Checklist (PCL, self-reported) at 25th hours post-infusion
Measured over For PCL, change in scores at 25th hour post-infusion compared to the baseline were measured
A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.
Who can take part
Eligibility, as published
Where
1 study site
| Facility | City | Region | Country |
|---|---|---|---|
| Cooper University Hospital | Camden | New Jersey | United States |
On the registry
Contact the trial directly
This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.
Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.
NCT02766192 on ClinicalTrials.gov →
Last updated in the registry 2016-05-09. Registry records change; this page reflects the data build of 2026-08-25.
Related